NOTE: ALL STOCKS IN THIS WATCHLIST ARE EITHER TRENDING TOWARDS A BULLISH TECHNICAL CHART OR CURRENTLY IN ONE. ANY TECHNICAL ANALYSIS IS PROVIDED IN THE CHART. PLEASE DO YOUR OWN DUE DILIGENCE BEFORE CONSIDERING INVESTING IN THESE STOCKS. (The Shares Float is based on figures from FinViz.Com).
Stocks highlighted in this watchlist include $IMUC, $RGSE, $NEOT.
IMUC: Shares float of 15.43 million. IMUC, a biotechnology company developing immunotherapies for the treatment of cancer based on Stem-to-T-Cell research, announced last week that Anthony Gringeri, Ph.D., President and Chief Executive Officer, Steven Swanson, Ph.D., Sr. VP, Research, and David Fractor, Chief Financial Officer, will present at the Lytham Partners Virtual Investor Conference on Wednesday, October 11, 2017 at 2:00 p.m. ET (11:00 a.m. PT). Immunotherapies are being widely investigated as a way to develop highly specific anticancer therapies. The goal of most of these immunotherapies is to create a population of killer T cells that are programmed to destroy tumor cells. The Stem-to-T-Cell research program, exhibits superiority to the existing standard of care.
RGSE: 7.02 million shares float. Real Goods Solar, Inc. (RGSE) Stock Skyrockets on Dow Deal on October 4th. The deal between Real Goods Solar, Inc. and Dow has to do with the latter’s solar panel efforts. DOW has been working on a new solar shingle called the Powerhouse 3.0. The shingle is designed to cost less than previous solar panels from the company and is more efficient. Real Goods Solar, Inc.’s agreement with Dow will have it handling all the commercial activities concerning the Powerhouse 3.0 solar shingles. This includes “supply chain management, marketing, sales, installation, and warranty.” Real Goods Solar, Inc. also now holds the exclusive licenses for patents that cover the Powerhouse 3.0. This will let it market the product overseas, which may be good news for RGSE stock. The market for building integrated photovoltaic goods is expected to increase from $2.5 billion in 2016 to $4.3 billion by 2021.
NEOT: Float of 10.8 million shares. No significant news lately but we're seeing a technical rise in stock price. With a volume of 7 x EMA(20) volume, there could be news on the horizon.